SUVEN PHARMACEUTICALS
Quarterly Results Analysis [Jun2025]
SUVEN PHARMACEUTICALS Quarterly Results
Consolidated | Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹549 Cr | ₹402 Cr | ₹307 Cr | ₹258 Cr | ₹488 Cr | ₹253 Cr | ₹220 Cr | ₹231 Cr |
Expenses | ₹437 Cr | ₹328 Cr | ₹189 Cr | ₹154 Cr | ₹363 Cr | ₹180 Cr | ₹154 Cr | ₹132 Cr |
Operating Income | ₹112 Cr | ₹74 Cr | ₹118 Cr | ₹104 Cr | ₹125 Cr | ₹73 Cr | ₹66 Cr | ₹99 Cr |
Other Income | ₹14 Cr | ₹11 Cr | ₹16 Cr | ₹14 Cr | ₹19 Cr | ₹17 Cr | ₹14 Cr | ₹20 Cr |
Interest | ₹10 Cr | ₹6 Cr | ₹3 Cr | ₹2 Cr | ₹10 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr |
Depreciation | ₹45 Cr | ₹27 Cr | ₹20 Cr | ₹17 Cr | ₹31 Cr | ₹17 Cr | ₹13 Cr | ₹12 Cr |
Profit Before Tax | ₹63 Cr | ₹52 Cr | ₹110 Cr | ₹100 Cr | ₹103 Cr | ₹71 Cr | ₹65 Cr | ₹105 Cr |
Profit After Tax | ₹46 Cr | ₹39 Cr | ₹83 Cr | ₹82 Cr | ₹75 Cr | ₹53 Cr | ₹47 Cr | ₹80 Cr |
EPS | ₹1.28 | ₹1.65 | ₹3.26 | ₹3.23 | ₹2.96 | ₹2.10 | ₹1.84 | ₹3.12 |
Industry Peers & Returns | 1W | 1M | 1Y |
SUVEN PHARMACEUTICALS | 10% | 6.3% | -15.1% |
SUN PHARMACEUTICAL INDUSTRIES | 0.7% | 0.4% | -12.5% |
DIVIS LABORATORIES | -1.7% | 2% | 16.7% |
CIPLA | -0.9% | 5.3% | -3.7% |
TORRENT PHARMACEUTICALS | -0.1% | 0.6% | 6.6% |
DR REDDYS LABORATORIES | 4.1% | 7.6% | -3% |
MANKIND PHARMA | 1.7% | 5.8% | 6.8% |
ZYDUS LIFESCIENCES | 2.7% | 11.1% | -5.8% |
LUPIN | 2% | 3.2% | -13.2% |
SUVEN PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 36.64 % |
Y-o-Y | 12.55 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2025 | ₹549 Cr | 36.64 | |
Mar2025 | ₹402 Cr | 30.89 | |
Dec2024 | ₹307 Cr | 19.18 | |
Sep2024 | ₹258 Cr | -47.20 | |
Jun2024 | ₹488 Cr | 92.97 | |
Mar2024 | ₹253 Cr | 15.06 | |
Dec2023 | ₹220 Cr | -4.86 | |
Sep2023 | ₹231 Cr | - |
SUVEN PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 52.27 % |
Y-o-Y | -10.46 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2025 | ₹112 Cr | 52.27 | |
Mar2025 | ₹74 Cr | -37.50 | |
Dec2024 | ₹118 Cr | 13.16 | |
Sep2024 | ₹104 Cr | -16.86 | |
Jun2024 | ₹125 Cr | 70.58 | |
Mar2024 | ₹73 Cr | 10.99 | |
Dec2023 | ₹66 Cr | -33.01 | |
Sep2023 | ₹99 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 11.42 % |
Y-o-Y | -20.44 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2025 | 20.39% | 11.42 | |
Mar2025 | 18.3% | -52.24 | |
Dec2024 | 38.32% | -5.05 | |
Sep2024 | 40.36% | 57.47 | |
Jun2024 | 25.63% | -11.62 | |
Mar2024 | 29% | -3.53 | |
Dec2023 | 30.06% | -29.59 | |
Sep2023 | 42.69% | - |
SUVEN PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 19.80 % |
Y-o-Y | -38.44 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2025 | ₹46 Cr | 19.80 | |
Mar2025 | ₹39 Cr | -53.50 | |
Dec2024 | ₹83 Cr | 1.60 | |
Sep2024 | ₹82 Cr | 8.77 | |
Jun2024 | ₹75 Cr | 41.22 | |
Mar2024 | ₹53 Cr | 14.16 | |
Dec2023 | ₹47 Cr | -41.23 | |
Sep2023 | ₹80 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -12.25 % |
Y-o-Y | -45.27 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2025 | 8.45 % | -12.25 | |
Mar2025 | 9.63 % | -64.49 | |
Dec2024 | 27.12 % | -14.74 | |
Sep2024 | 31.81 % | 106.02 | |
Jun2024 | 15.44 % | -26.82 | |
Mar2024 | 21.1 % | -0.80 | |
Dec2023 | 21.27 % | -38.22 | |
Sep2023 | 34.43 % | - |
SUVEN PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -22.42 % |
Y-o-Y | -56.76 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2025 | ₹1.28 | -22.42 | |
Mar2025 | ₹1.65 | -49.39 | |
Dec2024 | ₹3.26 | 0.93 | |
Sep2024 | ₹3.23 | 9.12 | |
Jun2024 | ₹2.96 | 40.95 | |
Mar2024 | ₹2.1 | 14.13 | |
Dec2023 | ₹1.84 | -41.03 | |
Sep2023 | ₹3.12 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD